Search Results 181-190 of 16613 for liraglutide
Mayo Clinic researchers have developed a genetic test that can help predict how people will respond to weight loss medications such as GLP-1s. Latest stories.
Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you ...
The primary objective of the trial is to evaluate the long-term safety of glepaglutide treatment in patients with short bowel syndrome (SBS). Glepaglutide is ...
Meditation. Yoga. Massage. Acupuncture. Use of supplements, such as vitamins, herbs and minerals. Music therapy. Integrative medicine aims to fit each person's ...
HIV is the virus that causes acquired immune deficiency syndrome (AIDS). This medicine is usually given to patients to replace their current anti-HIV medicines ...
Placebo-controlled, Proof-of-concept Study To Evaluate The Safety And Efficacy Of Lanifibranor Alone And In Combination With SGLT2 Inhibitor EmpaGliflozin ...
Pegaptanib is used to treat neovascular (wet) age-related macular degeneration (AMD). AMD is a disorder of the retina of the eye that causes blurring of vision ...
Know what claims about weight loss mean ... You might be surprised to learn that makers of dietary supplements rarely do clinical trials. That's part of the ...
This phase II trial studies how well nivolumab and brentuximab vedotin work in treating older patients with untreated Hodgkin lymphoma. Monoclonal antibodies, ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift doubles in impact to help more patients.